Australia markets open in 4 hours 42 minutes

Zealand Pharma A/S (ZEAL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
32.00+1.33 (+4.34%)
As of 1:08PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close30.67
Open30.71
Bid30.63 x 800
Ask32.60 x 1100
Day's range30.55 - 32.00
52-week range24.97 - 40.96
Volume4,212
Avg. volume22,268
Market cap1.393B
Beta (5Y monthly)0.87
PE ratio (TTM)N/A
EPS (TTM)-4.32
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est38.00
  • GlobeNewswire

    Total number of shares and voting rights in Zealand Pharma at September 30, 2021

    Company announcement – No. 62 / 2021 Total number of shares and voting rights in Zealand Pharma at September 30, 2021 Copenhagen, DK and Boston, MA, September 30, 2021 – Zealand Pharma A/S (β€œZealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at

  • GlobeNewswire

    Transactions in Zealand Pharma sharesΒ and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

    Company announcement – No. 61 / 2021 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, DK and Boston, MA, U.S., September ο»Ώ10, 2021 – Zealand Pharma A/S (β€œZealand”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, has received information on transactions in Zealand's shares

  • GlobeNewswire

    Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

    Company announcement – No. 60 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S. September 10, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 30,748 divided into 30,748 new shares with a nominal value of DKK 1 each. The